IL87221A - 7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them - Google Patents

7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them

Info

Publication number
IL87221A
IL87221A IL87221A IL8722188A IL87221A IL 87221 A IL87221 A IL 87221A IL 87221 A IL87221 A IL 87221A IL 8722188 A IL8722188 A IL 8722188A IL 87221 A IL87221 A IL 87221A
Authority
IL
Israel
Prior art keywords
naphthyridine
aminopyrrolidinyl
methyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL87221A
Other languages
English (en)
Other versions
IL87221A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL87221A0 publication Critical patent/IL87221A0/xx
Publication of IL87221A publication Critical patent/IL87221A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
IL87221A 1987-08-04 1988-07-26 7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them IL87221A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8141687A 1987-08-04 1987-08-04
US07/160,950 US4962112A (en) 1987-08-04 1988-02-26 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds

Publications (2)

Publication Number Publication Date
IL87221A0 IL87221A0 (en) 1988-12-30
IL87221A true IL87221A (en) 1993-02-21

Family

ID=26765562

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87221A IL87221A (en) 1987-08-04 1988-07-26 7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4962112A (fr)
EP (1) EP0302371B1 (fr)
JP (1) JP2645091B2 (fr)
KR (1) KR970007918B1 (fr)
AT (1) ATE115575T1 (fr)
AU (1) AU615934B2 (fr)
CA (1) CA1340784C (fr)
DE (1) DE3852442T2 (fr)
DK (1) DK169786B1 (fr)
ES (1) ES2068190T3 (fr)
GR (1) GR3015404T3 (fr)
IE (1) IE65175B1 (fr)
IL (1) IL87221A (fr)
NZ (1) NZ225584A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83049A (en) * 1986-07-04 1991-12-12 Chemie Linz Ag 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
IL91648A (en) * 1988-09-22 1997-03-18 Abbott Lab Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
CA2012681A1 (fr) * 1989-03-31 1990-09-30 Masayasu Okuhira Derives de la quinolone, procedes de preparation et agents antibacteriens les renfermant
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
CN1054980A (zh) * 1990-02-19 1991-10-02 杏林制药株式会社 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物,它们的制备方法以及它们的中间体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
US4616019A (en) * 1984-01-26 1986-10-07 Abbott Laboratories Naphthyridine antibacterial compounds
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩

Also Published As

Publication number Publication date
DE3852442T2 (de) 1995-04-27
ES2068190T3 (es) 1995-04-16
EP0302371A2 (fr) 1989-02-08
EP0302371A3 (en) 1989-10-18
EP0302371B1 (fr) 1994-12-14
DK435388A (da) 1989-02-05
ATE115575T1 (de) 1994-12-15
DK435388D0 (da) 1988-08-04
JPS6450880A (en) 1989-02-27
KR890003755A (ko) 1989-04-17
IL87221A0 (en) 1988-12-30
AU2037188A (en) 1989-02-09
KR970007918B1 (ko) 1997-05-17
US4962112A (en) 1990-10-09
DE3852442D1 (de) 1995-01-26
DK169786B1 (da) 1995-02-27
JP2645091B2 (ja) 1997-08-25
GR3015404T3 (en) 1995-06-30
IE65175B1 (en) 1995-10-04
NZ225584A (en) 1990-06-26
AU615934B2 (en) 1991-10-17
IE882231L (en) 1989-02-04
CA1340784C (fr) 1999-10-12

Similar Documents

Publication Publication Date Title
IL72100A (en) 6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions comprising them
GR3017850T3 (en) Pyrazolopyridine compound and processes for preparation thereof.
EP0342675A3 (en) Novel quinolonecarboxylic acid derivatives
IL93938A0 (en) Novel quinoline derivatives,preparation processes thereof,and antibacterial agents containing the same
EP0223385A3 (en) 8-azabicycloû3,2,1¨octane and 9-azabicycloû3,3,1¨nonane derivatives
IL84917A0 (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
ES8801290A1 (es) Un metodo para preparar derivados de cefem
HUT72434A (en) Novel pyridone carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their production
IL87221A (en) 7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them
NZ222185A (en) N-substituted methanesulphonamide derivatives, and anticancer compositions containing such
ES8604959A1 (es) Un compuesto
NZ225659A (en) Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
HUT41773A (en) Process for producing 2-/ 4-substituted-amino-3-oxo-2-isoxazolidinyl-5-oxo-2-tetrahydrofurane-carboxylic acid derivatives and pharmaceutical compositions containing them
IL95619A0 (en) N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them
NZ225763A (en) Pyrrolo (2,1-a) isoquinoline derivatives
DE3650023D1 (de) Beta-Lactamverbindungen und deren Herstellung.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired